Manufacturing review of the device history record for the reported lot shows that all units were quality released on 9/27/2016 having met all internal qc acceptance requirements.All sterilization records, and bioburden testing indicate successful sterilization process, and passing lal and product sterility results allowed the lot to be released having met all criteria for manufacturing release.There were no non-conformances associated with the manufacturing lot during production, sterilization and final packaging.The site investigator noted that the event is possibly related to the procedure and possibly related to the device.The probable cause is listed as, "procedure".However the exact relationship to the device cannot be conclusively determined as the device was not returned for evaluation.The instructions for use (lb-20266 provided with device) for the cangaroo ecm envelope currently lists hematoma as potential complications associated with the procedure and device.
|
The subject is a (b)(6) year old male who had an initial procedure of icd replaced with a cardiac resynchronization therapy defibrillator (crt-d) on (b)(6) 2017 where the ecm (cmcv-009-xlg, lot # m16h1214) was hydrated in normal saline (unknown length of time).At the subjects incision check on (b)(6) 2017, a moderate hematoma was noted at the incision site.At the 4-6 week visit on (b)(6) 2017 the hematoma was resolved.This required no intervention.The site investigator states that the event is possibly related to the procedure and possibly related to the device.The probable cause is listed as "procedure".
|